Peripheral Treg count and it's determinants in unsensitized and sensitized chronic kidney disease patients

International Urology and Nephrology

Volumn 45, Issue 6, 2013, Pages 1647-1652

  Topal, Cansu ^a   Köksoy, Sadi ^a   Süleymanlar, Gültekin ^a   Yakuboğlu, Gülşen ^a   Fevzi Ersoy, F ^a  

^a AKDENIZ UNIVERSITY   (Turkey)

Author keywords

Chronic kidney disease (CKD); HLADR; Immunoregulation; Kidney transplantation; Panel reactive antibody (PRA); Treg

Indexed keywords

CD4 ANTIGEN; HLA ANTIBODY; INTERLEUKIN 2 RECEPTOR ALPHA; TRANSCRIPTION FACTOR FOXP3;

ADULT; ANTIBODY RESPONSE; ANTIGEN EXPRESSION; ARTICLE; CELLULAR IMMUNODEFICIENCY; CHRONIC KIDNEY DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; END STAGE RENAL DISEASE; FEMALE; FLOW CYTOMETRY; HEMODIALYSIS; HUMAN; HUMAN CELL; LYMPHOCYTE COUNT; LYMPHOCYTE FUNCTION; MALE; MIDDLE AGED; PERIPHERAL BLOOD MONONUCLEAR CELL; PERITONEAL DIALYSIS; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; SENSITIZATION;

ADULT; AUTOANTIBODIES; CASE-CONTROL STUDIES; CD4 LYMPHOCYTE COUNT; FEMALE; GENOTYPE; HLA ANTIGENS; HLA-DR2 ANTIGEN; HUMANS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; RENAL INSUFFICIENCY, CHRONIC; T-LYMPHOCYTES, REGULATORY;

EID: 84890793839     PISSN: 03011623     EISSN: 15732584     Source Type: Journal    
DOI: 10.1007/s11255-013-0460-9     Document Type: Article

References (22)

1. National Kidney Foundation (2002) K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 39(Suppl 1):S1-S266
2. Akin Y, Koksoy S, Yucel S et al (2011) Increased peripheral CD4+ CD25 high Treg in prostate cancer patients is correlated with PSA. Saudi Med J 32:1003-1008
3. Amore A, Coppo R (2002) Immunological basis of inflammation in dialysis. Nephrol Dial Transplant 17(Suppl 8):16-24
4. Beimler JH, Susal C, Zeier M (2006) Desensitization strategies enabling successful renal transplantation in highly sensitized patients. Clin Transplant 20(Suppl 17):7-12
5. Bertrams J, Kuwert E, Liedtke U (1972) HL-A antigens and multiple sclerosis. Tissue Antigens 2:405-408
6. Gavin MA, Rasmussen JP, Fontenot JD et al (2007) Foxp3-dependent programme of regulatory T-cell differentiation. Nature 445:771-775
7. Ghiringhelli F, Larmonier N, Schmitt E et al (2004) CD4+ CD25+ regulatory T cells suppress tumor immunity but are sensitive to cyclophosphamide which allows immunotherapy of established tumors to be curative. Eur J Immunol 34:336-344
8. Girndt M, Sester U, Sester M et al (1999) Impaired cellular immune function in patients with end-stage renal failure. Nephrol Dial Transplant 14:2807-2810
9. Hendrikx TK, van Gurp EA, Mol WM et al (2009) End-stage renal failure and regulatory activities of CD4+ CD25bright+ FoxP3+ T-cells. Nephrol Dial Transplant 24:1969-1978
10. Hori S, Nomura T, Sakaguchi S (2003) Control of regulatory T cell development by the transcription factor Foxp3. Science 299:1057-1061
11. Kohler H, Arnold W, Renschin G et al (1984) Active hepatitis B vaccination of dialysis patients and medical staff. Kidney Int 25:124-128
12. Kurz P, Kohler H, Meuer S et al (1986) Impaired cellular immune responses in chronic renal failure: evidence for a T cell defect. Kidney Int 29:1209-1214
13. Libetta C, Esposito P, Sepe V et al (2010) Dialysis treatment and regulatory T cells. Nephrol Dial Transplant 25:1723-1727
14. Maisonneuve P, Agodoa L, Gellert R et al (1999) Cancer in patients on dialysis for end-stage renal disease: an international collaborative study. Lancet 354:93-99
15. Meier P, Golshayan D, Blanc E et al (2009) Oxidized LDL modulates apoptosis of regulatory T cells in patients with ESRD. J Am Soc Nephrol 20:1368-1384
16. Meyer TW, Hostetter TH (2007) Uremia. N Engl J Med 357:1316-1325
17. Olsen SK, Brown RS Jr (2006) Hepatitis B treatment: lessons for the nephrologist. Kidney Int 70:1897-1904
18. Patel R, Terasaki PI (1969) Significance of the positive crossmatch test in kidney transplantation. N Engl J Med 280:735-739
19. Sakaguchi S, Sakaguchi N, Asano M et al (1995) Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 155:1151-1164
20. Sakaguchi S, Yamaguchi T, Nomura T, Ono M (2008) Regulatory T cells and immune tolerance. Cell 133:775-787
21. Trzonkowski P, Szarynska M, Mysliwska J, Mysliwski A (2009) Ex vivo expansion of CD4(+) CD25(+) T regulatory cells for immunosuppressive therapy. Cytometry A 75:175-188
22. Velthuis JH, Mol WM, Weimar W, Baan CC (2006) CD4+ CD25bright+ regulatory T cells can mediate donor nonreactivity in long-term immunosuppressed kidney allograft patients. Am J Transplant 6:2955-2964